跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZIIHERA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZIIHERA
Authorized
STANDARD
ZIIHERA
JAZZ PHARMACEUTICALS IRELAND LIMITED
🇨🇦 Health Canada
Approval Date
Mar 30, 2026
Approval ID
1b30120f20d40223
Company
JAZZ PHARMACEUTICALS IRELAND LIMITED
Type
Standard
Approval Details
Approval Id
1b30120f20d40223
Drug Approval Canada Name
ZIIHERA
Product Name
ZIIHERA
Status
Approved
Status Date
2026-01-15
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
PRESCRIPTION , SCHEDULE D
Ahfs
10:00.00
Atc Original
L01FD07 ZANIDATAMAB
Aig Number
0168053001
Company Name
JAZZ PHARMACEUTICALS IRELAND LIMITED
Company Address
5th Floor, Waterloo Exchange, Waterloo Rd. Dublin Dublin Ireland D04 E5W7
Company Detail Path
/organization/jazz-pharmaceuticals-ireland-limited
Company Information
Pharmaceutical Company Name
JAZZ PHARMACEUTICALS IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
5th Floor Waterloo Exchange
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Mar 30, 2026
Approval ID
1b30120f20d40223
Type
Standard
Back to Health Canada Approvals